Differences and similarities of industrial and institutional promotions;Différences et similitudes des promotions industrielles et des promotions institutionelles

Medecine/Sciences

Volumn 22, Issue 10, 2006, Pages 881-886

  Ménard, Joël ^a   Daurat, Véronique ^b  

^a SPIM   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; CLINICAL STUDY; HEALTH CARE SYSTEM; INDUSTRIAL MEDICINE; INSTITUTIONAL CARE; MEDICAL PRACTICE; MEDICAL RESEARCH; MEDICAL SOCIETY; PATIENT MONITORING; QUALITY CONTROL; REVIEW; RISK MANAGEMENT;

EID: 33750063675     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/20062210881     Document Type: Review

References (16)

1. Grimes DA, Hubacher D, Nanda K, et al. The good clinical practice guideline: a bronze standard for clinical research. Lancet 2005; 366: 172-4.
2. Lievre M, Menard J, Bruckert E, et al. Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility. Br Med J 2001; 322: 603-5.
3. Psaty BM, Rennie D. Stopping medical research to save money: a broken pact with researchers and patients. JAMA 2003; 289: 2128-31.
4. Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. Vigor study group. N Engl J Med 2000; 343: 1520-8.
5. Silverstein F, Simon L, Faich G. Reporting of 6-month versus 12-month data in a clinical trial of Celocoxib. JAMA 2001; 286: 2398-400.
6. Steinbrook R. Protecting research subjects: the crisis at Johns Hopkins. N Engl J Med 2002; 346: 716-20.
7. Ray WA, Stein CM. Reform of drug regulation-beyond an independent drug-safety board. N Engl J Med 2006; 354: 194-201.
8. Brun-Buisson C. Les DSMB. 1. Quel rôle, quelles responsabilités? Med Sci (Paris) 2005; 21: 78-82.
9. Brun-Buisson C. Les DSMB. 2.De l'importance d'un DSMB efficace, exemples d'essais cliniques à risque. Med Sci (Paris) 2005; 21: 187-9.
10. Ioannidis JP. Why most published research findings are false. PLoS Med 2005; 2: e124.
11. Hampton T. Biomedical journals probe peer review. JAMA 2005; 294: 2287-8.
12. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-5.
13. Angell M. The truth about the drug companies. New York: Random House, 2004.
14. Daurat V. Les règles de l'AP-HP promoteur. Journal de la DRRC de l'Ile-de-France 2002; 1: 3.2.
15. Daurat V. Les règles de l'AP-HP promoteur. Lettre de la DRRC de l'Ile-de-France 2002; 2: 3.3.1.
16. Ménard J. Qui a tué Ellen Roche? Lettre de la DRRC de l'Ile-de-France 2002; 2: 3.2.